EMA approves hypertension and Parkinson’s generics / News / Generics / Home - GaBi Online

EMA approves hypertension and Parkinson’s generics

Generics/News | Posted 17/05/2019 1 Post your comment

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) announced on 26 April 2019 that it had recommended granting marketing authorization for hypertension and Parkinson’s generics.

During the CHMP’s meeting of 23−26 April 2019, the committee recommended granting marketing authorizations for two generics: Ambrisentan Mylan (ambrisentan), for the treatment of pulmonary arterial hypertension, and Striascan [ioflupane (123I)], a radiopharmaceutical intended for the diagnosis of Parkinson’s disease and other related diseases and dementia.

Ambrisentan Mylan is a generic version of GlaxoSmithKline’s endothelin receptor antagonist (ERA) Volibris (ambrisentan). Volibris is indicated for the treatment of pulmonary hypertension, which is a type of high blood pressure that affects the arteries in the lungs and the right side of the heart.

Striascan is made by CIS BIO International. It is a generic version of GE Healthcare’s DaTSCAN [ioflupane (123I)], which is a neuro-imaging radiopharmaceutical drug, used by nuclear medicine physicians for the diagnosis of Parkinson's disease and the differential diagnosis of Parkinson's disease over other disorders presenting similar symptoms.

Ambrisentan Mylan has been approved as 5 mg and 10 mg film-coated tablets. Striascan has been approved as a solution for injection (74 MBq/mL). The CHMP states that studies for both generics have demonstrated the satisfactory quality of the two products and their bioequivalence to the relevant reference products.

Permission granted to reproduce for personal and non-commercial use only. All other reproduction, copy or reprinting of all or part of any ‘Content’ found on this website is strictly prohibited without the prior consent of the publisher. Contact the publisher to obtain permission before redistributing.

Source: EMA

Comments (1)

Post your comment

Posted 03/07/2025 by Susan Baker

HERBS

My husband was diagnosed of Parkinsons disease 2 years ago, when he was 49. He had a stooped posture, tremors, right arm does not move and also a pulsating feeling in his body. He was placed on Senemet for 8 months and then Sifrol was introduced and replaced the Senemet, during this time span he was also diagnosed with dementia. He started having hallucinations, lost touch with reality. Suspecting it was the medication I took him off the Siferol (with the doctor’s knowledge) and started him on PD-5 natural herbal formula we ordered from AKNNI HERBAL CENTRE, his symptoms totally declined over a 3 weeks use of the AKANNI HERBAL Parkinsons disease natural herbal formula. He is now almost 51 and doing very well, the disease is totally reversed! (Visit w w w.aknniherbscentre .com)